|  | Outcomes | Number of reviews (%) |
---|---|---|---|
Clinical effects | 1 | Clinical effectiveness | 28 (38.4) |
2 | Total effectiveness | 48 (65.8) | |
3 | Cure rate | 12 (16.4) | |
4 | Significant effectiveness | 2 (2.7) | |
5 | Inefficiency rate | 2 (2.7) | |
6 | Recurrence rate | 23 (31.5) | |
Adverse reaction | 7 | Adverse reaction rate | 42 (57.5) |
Immune factor levels | 8 | TNF-a | 5 (6.8) |
9 | IL-6 | 5 (6.8) | |
10 | IL-8 | 3 (4.1) | |
11 | IL-10 | 1 (1.4) | |
12 | IL-13 | 1 (1.4) | |
13 | IL-17 | 3 (4.1) | |
14 | IL-23 | 3 (4.1) | |
Infection screening | 15 | CRP | 7 (9.6) |
16 | ESR | 5 (6.8) | |
Performance of colonoscopy | 17 | Performance of colonoscopy | 20 (27.4) |
18 | Mucosal biopsy score | 4 (5.5) | |
19 | Efficacy of mucosal lesions | 1 (1.4) | |
Clinical symptoms | 20 | TCM syndrome score | 14 (19.2) |
21 | DAI | 9 (12.3) | |
22 | Abdominal pain | 6 (8.2) | |
23 | Diarrhea | 6 (8.2) | |
24 | Pus and blood stool | 6 (8.2) | |
25 | Tenesmus | 3 (4.1) | |
26 | Time of bellyache disappearance | 3 (4.1) | |
27 | Time of diarrhea disappearance | 3 (4.1) | |
28 | Time of hematochezia disappearance | 2 (2.7) | |
29 | Time of fever disappearance | 2 (2.7) | |
30 | Defecate occult blood | 2 (2.7) | |
31 | Total symptom score before and after treatment | 1 (1.4) | |
32 | Geboes index | 1 (1.4) | |
33 | Symptom relief time | 1 (1.4) | |
34 | Intervention treatment | 1 (1.4) | |
Serum inflammatory cytokines levels | 35 | IgG | 4 (5.5) |
36 | IgA | 3 (4.1) | |
37 | IgM | 2 (2.7) | |
Blood routine | 38 | Negative conversion rate of White blood cells and red blood cells in stool routine | 1 (1.4) |
39 | Whole blood viscosity score | 1 (1.4) | |
40 | Plasma viscosity | 1 (1.4) | |
Level of intestinal flora | 41 | Bifidobacterium level | 1 (1.4) |
42 | Lactobacillus level | 1 (1.4) | |
43 | Enterococcus level | 1 (1.4) | |
44 | E. coli level | 1 (1.4) |